Related references
Note: Only part of the references are listed.H3K27me3 loss indicates an increased risk of recurrence in the Tubingen meningioma cohort
Felix Behling et al.
NEURO-ONCOLOGY (2021)
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631
Patrick A. Brown et al.
LEUKEMIA (2021)
The substantial loss of H3K27me3 can stratify risk in grade 2, but not in grade 3 meningioma
Minsun Jung et al.
HUMAN PATHOLOGY (2021)
Prognostic Value of Histopathological Features and Loss of H3K27me3 Immunolabeling in Anaplastic Meningioma: A Multicenter Retrospective Study
Guillaume Gauchotte et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)
CANCER GENETICS Epigenetic cancer evolution, one cell at a time
Carolina N. Perdigoto
NATURE REVIEWS GENETICS (2019)
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence
Leah M. Katz et al.
ACTA NEUROPATHOLOGICA (2018)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2018)
Emerging Medical Treatments for Meningioma in the Molecular Era
Fares Nigim et al.
BIOMEDICINES (2018)
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
Felix Sahm et al.
LANCET ONCOLOGY (2017)
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2017)
Genomic profile of human meningioma cell lines
Yu Mei et al.
PLOS ONE (2017)
Genetic and epigenetic alterations in meningiomas
Vasiliki Galani et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2017)
Role of Merlin/NF2 inactivation in tumor biology
A. M. Petrilli et al.
ONCOGENE (2016)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2016)
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review
Leland Rogers et al.
JOURNAL OF NEUROSURGERY (2015)
A review of epigenetic and gene expression alterations associated with intracranial meningiomas
Shuhan He et al.
NEUROSURGICAL FOCUS (2013)
Impaired survival and long-term neurological problems in benign meningioma
Hanna van Alkemade et al.
NEURO-ONCOLOGY (2012)
Deacetylation and methylation at histone H3 lysine 9 (H3K9) coordinate chromosome condensation during cell cycle progression
Jin-Ah Park et al.
MOLECULES AND CELLS (2011)
AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas
Matthew L. Bush et al.
NEURO-ONCOLOGY (2011)
The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments
Winward Choy et al.
NEUROSURGICAL FOCUS (2011)
Decellularized Porcine Brain Matrix for Cell Culture and Tissue Engineering Scaffolds
Jessica A. DeQuach et al.
TISSUE ENGINEERING PART A (2011)
Hypermethylation and Transcriptional Downregulation of the TIMP3 Gene is Associated with Allelic Loss on 22q12.3 and Malignancy in Meningiomas
Dimitri Barski et al.
BRAIN PATHOLOGY (2010)
LONG-TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATION
Manish K. Aghi et al.
NEUROSURGERY (2009)
Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes
CS Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L
R Rong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings
O Al-Mefty et al.
JOURNAL OF NEUROSURGERY (2004)
DNA methylation of multiple promoter-associated CpG islands in meningiomas:: relationship with the allelic status at 1p and 22q
MJ Bello et al.
ACTA NEUROPATHOLOGICA (2004)
Share Paper
